MAOB
MOLECULAR TARGETmonoamine oxidase B
MAOB (monoamine oxidase B) is targeted by 19 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting MAOB
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | Iproniazid | 4.37 | 78 |
| 2 | Moclobemide | 2.71 | 14 |
| 3 | Phenelzine | 1.95 | 6 |
| 4 | Pioglitazone | 1.95 | 6 |
| 5 | Genistein | 1.79 | 5 |
| 6 | Farnesol | 1.61 | 4 |
| 7 | Zonisamide | 1.61 | 4 |
| 8 | Idazoxan | 1.39 | 3 |
| 9 | Vitamin K 3 | 1.39 | 3 |
| 10 | Troglitazone | 1.39 | 3 |
| 11 | auraptene | 1.10 | 2 |
| 12 | hispidol | 1.10 | 2 |
| 13 | Linezolid | 1.10 | 2 |
| 14 | Apigenin 5,7,4'-trihydroxy-flavone, | 0.69 | 1 |
| 15 | chrysin | 0.69 | 1 |
| 16 | Resveratrol | 0.69 | 1 |
| 17 | Emodin Purgative anthraquinone found in several plants, especially RHAMNUS PURSHIANA. It was formerly used as | 0.69 | 1 |
| 18 | Fentanyl | 0.69 | 1 |
| 19 | Rilmenidine Oxazole derivative that acts as | 0.69 | 1 |
About MAOB as a Drug Target
MAOB (monoamine oxidase B) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 19 compounds with documented MAOB interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
MAOB inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.